GLEN REBMAN: Open Payments
NPI 1487181558 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 6 payments from 4 companies in 2025. Trend: 2023 $154 · 2024 $1,926 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 3 | $189 |
| LivaNova USA, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, Jornay PM, TRINTELLIX.
Industry payments across MN — which companies pay providers there.
